The same research group has registered a clinical trial for IN Insulin in Frontotemporal Dementia (FTD) in 12 patients, which is critical, as no treatment medicines for the advancing cognitive symptoms of FTD have been developed. This evidence concerns the gene INS and frontotemporal dementia.